© 1993 Oxford University Press
research-article |
Chemically induced skin carcinogenesis in a transgenic mouse line (TG·AC) carrying a v-Ha-ras gene
Laboratory of Experimental Carcinogenesis and Mutagenesis National Institute of Environmental Health Sciences PO Box 12233, Research Triangle Park, NC 27709, USA
1Laboratory of Experimental Toxicology, National Institute of Environmental Health Sciences PO Box 12233, Research Triangle Park, NC 27709, USA
A transgenic mouse line (TG·AC) created in the FVB/N strain, carries a v-Ha-ras gene fused to
-globin promoter gene. These trangenic mice have the properties of genetically initiated skin and have been shown to be sensitive to 12-O-tetradecanoylphorbol-13-acetate (TPA), a well-described promoter of skin papillomas in the two-stage mouse skin tumorigenesis model. It was of interest to determine whether the TG·AC mouse strain was also responsive to other known promoters. Groups of heterozygous or homozygous TG·AC mice were treated topically, 2×/week, for up to 20 weeks with benzoyl peroxide (BPO), 2-butanol peroxide (2-BUP), phenol (PH), acetic acid (AA), TPA and acetone (ACN), the vehicle control. Skin papillomas were induced in all groups treated with TPA, BPO and 2-BUP. Papillomas were observed in some treatment groups as early as 3 weeks. The relative activity of the promoters was TPA>2-BUP> BPO>PH=AA=ACN. No papillomas were observed in any of the uninitiated FVB/N mice treated in a similar manner and which served as treatment control groups. Studies to determine the sensitivity of TG·AC mice to TPA, indicated that a total dose of 2530 µg of TPA administered in 3 or 10 applications, was sufficient to induce an average incidence of 1115 papillomas per mouse. The papilloma incidence continued to increase and was maintained up to 15 weeks after TPA treatment was terminated. The short latency period and high incidence of papilloma induction indicate that TG·AC mice have a high sensitivity to known skin promoters. The TG·AC line should prove to be a sensitive model for identifying putative tumor promoters or complete carcinogens.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Lynch, J. Svoboda, S. Putta, H. E. J. Hofland, W. H. Chern, and L. A. Hansen Mouse Skin Models for Carcinogenic Hazard Identification: Utilities and Challenges Toxicol Pathol, December 1, 2007; 35(7): 853 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Oki-Idouchi and P. S. Lorenzo Transgenic Overexpression of RasGRP1 in Mouse Epidermis Results in Spontaneous Tumors of the Skin Cancer Res., January 1, 2007; 67(1): 276 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Curtin, M. Hanausek, Z. Walaszek, R. Zoltaszek, J. E. Swauger, A. T. Mosberg, and T. J. Slaga Short-Term Biomarkers of Cigarette Smoke Condensate Tumor Promoting Potential in Mouse Skin Toxicol. Sci., January 1, 2006; 89(1): 66 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fuhrman, L. Shafer, S. Repertinger, T. Chan, and L. A. Hansen Mechanisms of SEPA 0009-Induced Tumorigenesis in v-rasHa Transgenic Tg.AC Mice Toxicol Pathol, October 1, 2005; 33(6): 623 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Doi, J. R. Hailey, M. Hejtmancik, J. D. Toft II, M. Vallant, and R. S. Chhabra Topical Application of Representative Multifunctional Acrylates Produced Proliferative and Inflammatory Lesions in F344/N Rats and B6C3F1 Mice, and Squamous Cell Neoplasms in Tg.AC Mice Toxicol Pathol, October 1, 2005; 33(6): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, R. Yao, J. Li, Y. Wang, C. W. Boone, R. A. Lubet, and M. You Induction of Invasive Mouse Skin Carcinomas in Transgenic Mice with Mutations in Both H-ras and p53 Mol. Cancer Res., October 1, 2005; 3(10): 563 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Regier, J. Higbee, K. M. Lund, F. Sakane, S. M. Prescott, and M. K. Topham Diacylglycerol kinase {iota} regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling PNAS, May 24, 2005; 102(21): 7595 - 7600. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Curtin, M. Hanausek, Z. Walaszek, A. T. Mosberg, and T. J. Slaga Short-Term In Vitro and In Vivo Analyses for Assessing the Tumor-Promoting Potentials of Cigarette Smoke Condensates Toxicol. Sci., September 1, 2004; 81(1): 14 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. McCormick and R. Kavet Animal Models for the Study of Childhood Leukemia: Considerations for Model Identification and Optimization to Identify Potential Risk Factors International Journal of Toxicology, May 1, 2004; 23(3): 149 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Wei, C. S. Trempus, R. C. Ali, L. A. Hansen, and R. W. Tennant 12-O-Tetradecanoylphorbol-13-acetate and UV Radiation-induced Nucleoside Diphosphate Protein Kinase B Mediates Neoplastic Transformation of Epidermal Cells J. Biol. Chem., February 13, 2004; 279(7): 5993 - 6004. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Payne and C. J. Kemp p27 Kip1 (Cdkn1b)-Deficient Mice Are Susceptible to Chemical Carcinogenesis and May Be a Useful Model for Carcinogen Screening Toxicol Pathol, June 1, 2003; 31(4): 355 - 363. [Abstract] [PDF] |
||||
![]() |
S. M. Allen, S. R. Florell, A. N. Hanks, A. Alexander, M. J. Diedrich, D. C. Altieri, and D. Grossman Survivin Expression in Mouse Skin Prevents Papilloma Regression and Promotes Chemical-induced Tumor Progression Cancer Res., February 1, 2003; 63(3): 567 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Wei, C. S. Trempus, R. E. Cannon, C. D. Bortner, and R. W. Tennant Identification of Dss1 as a 12-O-Tetradecanoylphorbol-13-acetate-responsive Gene Expressed in Keratinocyte Progenitor Cells, with Possible Involvement in Early Skin Tumorigenesis J. Biol. Chem., January 10, 2003; 278(3): 1758 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Sistare, K. L. Thompson, R. Honchel, and J. DeGeorge Evaluation of the Tg.AC Transgenic Mouse Assay for Testing the Human Carcinogenic Potential of Pharmaceuticals--Practical Pointers, Mechanistic Clues, and New Questions International Journal of Toxicology, January 1, 2002; 21(1): 65 - 79. [Abstract] [PDF] |
||||
![]() |
N. Ahmad, A. C. Gilliam, S. K. Katiyar, T. G. O'Brien, and H. Mukhtar A Definitive Role of Ornithine Decarboxylase in Photocarcinogenesis Am. J. Pathol., September 1, 2001; 159(3): 885 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Stoll, S. M. Furst, J. H. Stoltz, P. D. Lilly, and J. H. Mennear Dermal Carcinogenicity in Transgenic Mice: Effect of Vehicle on Responsiveness of Hemizygous Tg.AC Mice to Phorbol 12-Myristate 13-Acetate (TPA) Toxicol Pathol, August 1, 2001; 29(5): 535 - 540. [Abstract] [PDF] |
||||
![]() |
M. StJ. Battalora, J. W. Spalding, C. J. Szczesniak, J. E. Cape, R. J. Morris, C. S. Trempus, C. D. Bortner, B. M. Lee, and R. W. Tennant Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse Carcinogenesis, April 1, 2001; 22(4): 651 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. French, G. D. Lacks, C. Trempus, J. K. Dunnick, J. Foley, J. Mahler, R. R. Tice, and R. W. Tennant Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent Carcinogenesis, January 1, 2001; 22(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Tennant, S. Stasiewicz, W. C. Eastin, J. H. Mennear, and J. W. Spalding The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model Toxicol Pathol, January 1, 2001; 29(1_suppl): 51 - 59. [Abstract] [PDF] |
||||
![]() |
W. C. Eastin, J. H. Mennear, R. W. Tennant, R. E. Stoll, D. G. Branstetter, J. R. Bucher, B. Mccullough, R. L. Binder, J. W. Spalding, and J. F. Mahler Tg.AC Genetically Altered Mouse: Assay Working Group Overview of Available Data Toxicol Pathol, January 1, 2001; 29(1_suppl): 60 - 80. [Abstract] [PDF] |
||||
![]() |
C. F. Van Kreijl, P. A. Mcanulty, R. B. Beems, A. Vynckier, H. Van Steeg, R. Fransson-Steen, C. L. Alden, R. Forster, J.-W. Van der Laan, and J. Vandenberghe Xpa and Xpa/p53+/- Knockout Mice: Overview of Available Data Toxicol Pathol, January 1, 2001; 29(1_suppl): 117 - 127. [Abstract] [PDF] |
||||
![]() |
K. L. Thompson, B. A. Rosenzweig, Y. Tsong, and F. D. Sistare Evaluation of in Vitro Reporter Gene Induction Assays for Use in a Rapid Prescreen for Compound Selection to Test Specificity in the Tg.AC Mouse Short-Term Carcinogenicity Assay Toxicol. Sci., September 1, 2000; 57(1): 43 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Dunson, J. K. Haseman, A. P. J. M. van Birgelen, S. Stasiewicz, and R. W. Tennant Statistical Analysis of Skin Tumor Data from Tg.AC Mouse Bioassays Toxicol. Sci., June 1, 2000; 55(2): 293 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment Toxicol Pathol, May 1, 2000; 28(3): 482 - 499. [Abstract] [PDF] |
||||
![]() |
H. E. Holden, R. E. Stoll, and K. T. Blanchard Oxymetholone: II. Evaluation in the Tg.AC Transgenic Mouse Model for Detection of Carcinogens Toxicol Pathol, September 1, 1999; 27(5): 507 - 512. [Abstract] [PDF] |
||||
![]() |
D. R. Germolec, J. Spalding, H.-S. Yu, G. S. Chen, P. P. Simeonova, M. C. Humble, A. Bruccoleri, G. A. Boorman, J. F. Foley, T. Yoshida, et al. Arsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors Am. J. Pathol., December 1, 1998; 153(6): 1775 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Robles, M. L. Rodriguez-Puebla, A. B. Glick, C. Trempus, L. Hansen, P. Sicinski, R. W. Tennant, R. A. Weinberg, S. H. Yuspa, and C. J. Conti Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo Genes & Dev., August 15, 1998; 12(16): 2469 - 2474. [Abstract] [Full Text] |
||||
![]() |
L. A. Nylander-French and J. E. French Tripropylene Glycol Diacrylate but Not Ethyl Acrylate Induces Skin Tumors in a Twenty-Week Short-Term Tumorigenesis Study in Tg.AC (v-Ha-ras) Mice Toxicol Pathol, July 1, 1998; 26(4): 476 - 483. [Abstract] [PDF] |
||||
![]() |
J. F. Mahler, N. D. Flagler, D. E. Malarkey, P. C. Mann, J. K. Haseman, and W. Eastin Spontaneous and Chemically Induced Proliferative Lesions in Tg.AC Transgenic and p53-Heterozygous Mice Toxicol Pathol, July 1, 1998; 26(4): 501 - 511. [Abstract] [PDF] |
||||
![]() |
S. Asano, C. S. Trempus, J. W. Spalding, R. W. Tennant, and M. StJ. Battalora Morphological Characterization of Spindle Cell Tumors Induced in Transgenic Tg.AC Mouse Skin Toxicol Pathol, July 1, 1998; 26(4): 512 - 519. [Abstract] [PDF] |
||||
![]() |
J. L. Weaver, J. F. Contrera, B. A. Rosenzweig, K. L. Thompson, P. J. Faustino, J. M. Strong, C. D. Ellison, L. W. Anderson, H. R. Prasanna, P. E. Long-Bradley, et al. An Evaluation of the Hemizygous Transgenic Tg.AC Mouse for Carcinogenicity Testing of Pharmaceuticals. I. Evidence for a Confounding Nonresponder Phenotype Toxicol Pathol, July 1, 1998; 26(4): 532 - 540. [Abstract] [PDF] |
||||
![]() |
K. T. Blanchard, D. J. Ball, H. E. Holden, S. M. Furst, J. H. Stoltz, and R. E. Stoll Dermal Carcinogenicity in Transgenic Mice: Relative Responsiveness of Male and Female Hemizygous and Homozygous Tg.AC Mice to 12-O-Tetradecanoylphorbol 13-Acetate (TPA) and Benzene Toxicol Pathol, July 1, 1998; 26(4): 541 - 547. [Abstract] [PDF] |
||||
![]() |
K. L. Thompson, B. A. Rosenzweig, and F. D. Sistare An Evaluation of the Hemizygous Transgenic Tg.AC Mouse for Carcinogenicity Testing of Pharmaceuticals. II. A Genotypic Marker that Predicts Tumorigenic Responsiveness Toxicol Pathol, July 1, 1998; 26(4): 548 - 555. [Abstract] [PDF] |
||||
![]() |
M. C. Humble, C. J. Szczesniak, N. C. Luetteke, J. W. Spalding, R. E. Cannon, L. A. Hansen, D. C. Lee, and R. W. Tennant TGF{alpha} is Dispensable for Skin Tumorigenesis in Tg.AC Mice Toxicol Pathol, July 1, 1998; 26(4): 562 - 569. [Abstract] [PDF] |
||||
![]() |
C. S. Trempus, S. Ward, G. Farris, D. Malarkey, R. S. Faircloth, R. E. Cannon, and J. F. Mahler Association of v-Ha-ras Transgene Expression with Development of Erythroleukemia in Tg.AC Transgenic Mice Am. J. Pathol., July 1, 1998; 153(1): 247 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Slaga Tumor Promotion and/or Enhancement Models International Journal of Toxicology, January 1, 1998; 17(3_suppl): 109 - 127. [PDF] |
||||
![]() |
B. F. Trump Mechanisms of Toxicity and Carcinogenesis Toxicol Pathol, November 1, 1995; 23(6): 775 - 827. [PDF] |
||||









